Cancer screening guidelines are usually organized by cancer type — mammography here, colonoscopy there. But most people think about cancer screening by decade: “I just turned 40 — what do I need now?” or “My doctor mentioned a colonoscopy at 45 — is that right?”
This guide organizes the same evidence-based recommendations into the format that matches how patients actually experience time: decade by decade, from your 20s through your 70s and beyond. A few things to know: these recommendations apply to average-risk adults with no personal cancer history, no hereditary syndrome, and no first-degree relatives diagnosed at unusually young ages. If your risk profile is elevated, your timeline likely starts earlier. And guidelines change — the 2024 USPSTF update moved mammography to begin at 40 rather than 50, a significant shift many patients haven’t heard yet.
Cancer Screening Quick Reference by Decade
| Decade | Recommended Cancer Screening (Average Risk) |
|---|---|
| 20s | Cervical: Pap smear every 3 years from age 21. Primary HPV testing every 5 years from age 25 (ACS preferred). |
| 30s | Cervical: continues (Pap q3y or HPV q5y or co-test q5y from age 30). No new average-risk screening. |
| 40s | Breast: mammography from age 40 (USPSTF 2024). CRC: starts at 45 (FIT annually or colonoscopy q10y). |
| 50s | Breast + CRC continue. Lung LDCT: starts at 50 for eligible smokers. Prostate PSA: shared discussion at 50–55. |
| 60s | All above continue. Cervical stops at 65 if adequate history. Prostate PSA: shared decision through 69. |
| 70s+ | CRC through 75 (individualized 76–85). Breast: individualized by life expectancy. Lung stops at 80. No PSA at 70+. |
In Your 20s: Cervical Cancer Screening and Awareness
For average-risk adults in their 20s, routine cancer screening is limited to cervical cancer screening for women — not a gap in the system, but a reflection of genuine cancer epidemiology. Most cancers are rare in adults under 30 outside of specific hereditary conditions.
- Ages 21–24: Pap smear every 3 years
- Ages 25–29: Primary HPV testing every 5 years (ACS preferred)
Cervical Cancer Screening — Starts at Age 21
USPSTF and ACS both recommend cervical screening begin at age 21 regardless of when sexual activity began. Ages 21–24: Pap smear every 3 years.
Why not before 21? HPV infection is common in sexually active young women — but the immune system clears the vast majority within two years. Cervical dysplasia in teenagers and early 20s almost never progresses to invasive cancer. Treating it with cervical procedures increases risk of preterm birth and cervical insufficiency. Screening before 21 generates more harm than benefit.
From age 25 (ACS 2020 preferred method), screening shifts to primary HPV testing every 5 years.
Testicular Awareness — Not a Formal Screening Test
Testicular cancer is the most common solid tumor in men aged 20–34. USPSTF does not recommend routine testicular cancer screening, but awareness is important. Young men who notice a painless testicular lump or scrotal swelling should have it evaluated promptly with ultrasound. The excellent prognosis of early-stage testicular cancer makes prompt evaluation worthwhile.
In Your 30s: Cervical Evolves, Family History Matters
- Primary HPV testing every 5 years (preferred) — OR co-test q5y — OR Pap q3y
- Co-testing option opens at age 30 (USPSTF)
No breast, CRC, lung, or prostate cancer screening is recommended for average-risk adults in their 30s. From age 30, an additional option opens for cervical screening: HPV co-testing (HPV + Pap) every 5 years, or primary HPV testing every 5 years. The longer 5-year interval is possible because primary HPV testing is more sensitive than Pap smear alone.
In Your 40s: The Big Change Decade
The 40s have seen the most significant recent guideline change — mammography now recommended from 40, and colorectal cancer screening beginning at 45. For many adults, the 40s introduce cancer screening for the first time.
- Breast: mammography every 2 years from age 40 (USPSTF 2024)
- Cervical: continues unchanged
- CRC (from age 45): FIT annually OR colonoscopy every 10 years OR Cologuard every 1–3 years OR CT colonography every 5 years
Breast Cancer Screening — Starts at 40 (USPSTF 2024)
In 2024, USPSTF updated its recommendation to begin mammography at age 40 rather than 50. This change was driven by updated modeling and data showing that Black women have substantially higher rates of breast cancer before age 50 and higher proportions of aggressive subtypes. Biennial mammography ages 40–74 — Grade B, covered without cost-sharing under the ACA.
ACS (2015): Women may begin annual mammography at 40–44 (optional); annual mammography formally recommended from 45. If your mammography report mentions dense breast tissue, ask your provider about supplemental screening options.
Colorectal Cancer Screening — Begins at Age 45
Colorectal cancer incidence in adults under 50 rose approximately 51% between 1994 and 2014 (Siegel et al., 2020, CA: A Cancer Journal for Clinicians) — the evidence that drove the lowering of the start age from 50 to 45. At age 45, choose one option:
- Annual FIT: At-home stool test; highly effective when done consistently each year; positive result requires colonoscopy follow-up
- Colonoscopy every 10 years: Allows polyp removal during procedure; first colonoscopy at 45 → next at 55 if no polyps found
- Stool DNA (Cologuard) every 1–3 years: Higher sensitivity, higher false positive rate; positive requires colonoscopy
- CT colonography every 5 years: No sedation; any polyp ≥6mm triggers colonoscopy
In Your 50s: The Most Screening-Intensive Decade
- Breast: mammography continues (biennial USPSTF; annual ACS option)
- CRC: FIT annually or colonoscopy continues
- Lung: annual LDCT from 50 (if 20+ pack-years + currently/recently smoked)
- Prostate: PSA shared decision-making discussion at 50 (ACS) or 55 (USPSTF)
Lung Cancer Screening — Begins at 50 (if Eligible)
USPSTF 2021 (Grade B — covered without cost-sharing) and ACS 2023 recommend annual LDCT for adults who are age 50–80, have 20 or more pack-years of smoking history, and currently smoke or quit within the past 15 years.
Pack-year calculation: Packs per day × years smoked. One pack/day × 20 years = 20 pack-years. Two packs/day × 15 years = 30 pack-years.
The test is annual low-dose CT of the chest — not a chest X-ray, which the PLCO trial showed is ineffective for lung cancer screening. About 25% of LDCT scans detect a pulmonary nodule; the vast majority are benign. Radiologists use the Lung-RADS classification for follow-up guidance. Lung cancer screening should always be accompanied by smoking cessation support.
Prostate Cancer Screening — Shared Decision-Making Begins
This is not automatic PSA testing — it is a structured discussion with your provider about the potential benefits and harms before deciding whether to test.
- ACS (2023): Discuss PSA at age 50 for average-risk men with ≥10 years life expectancy
- USPSTF (2018): Begin shared decision-making at age 55 (Grade C)
- High-risk men: Black men and those with a first-degree relative with prostate cancer before age 65 → discussion at age 45
If PSA testing proceeds: PSA below 2.5 ng/mL → retest every 2 years; PSA at or above 2.5 ng/mL → annual testing. A high PSA does not mean cancer — BPH and prostatitis are common causes in men in their 50s.
In Your 60s: Maintenance and Two Major Milestones
- Breast: mammography continues through 74 (USPSTF) — Medicare covers free at 65
- CRC: continues through 75 (USPSTF Grade A)
- Lung: LDCT continues through 80 for eligible smokers
- Cervical: STOP at 65 if adequate prior history (3 negative Paps or 2 negative co-tests in past 10 years)
- Prostate: PSA shared decision-making through 69; USPSTF Grade D at 70+
Cervical cancer screening stops at age 65 for most women with adequate prior screening history. Women with a history of abnormal results or inadequate prior screening should complete an adequate series before stopping. After age 65, no further cervical screening is needed if criteria are met.
In Your 70s and Beyond: Life Expectancy Drives Everything
- CRC: Grade A through 75; individualized 76–85; stop at 86+
- Breast: individualized (USPSTF insufficient evidence at 75+; ACS continues with ≥10yr life expectancy)
- Lung: LDCT through age 80 — stops after 80
- Prostate: No PSA — USPSTF Grade D at 70+
The core question in the 70s becomes: will this person live long enough to benefit from screening? Most cancer screening programs require 5–10 years for the benefit of earlier detection to appear as a survival advantage. Life expectancy and overall health status overtake age-based guidelines as the primary driver of screening decisions.
A healthy 77-year-old with no significant comorbidities continuing biennial mammography or CRC screening is making a reasonable and evidence-consistent choice. An 83-year-old with multiple serious comorbidities and limited life expectancy may derive little benefit and meaningful burden from continued screening — that conversation belongs with their physician.
When Risk Moves the Timeline Earlier
| Cancer | Average Start | High-Risk Modification |
|---|---|---|
| Breast | 40 (mammogram) | Age 25: BRCA1 annual MRI. Age 25–30: BRCA2 annual MRI. Prior chest radiation before 30: MRI 8 years post-radiation or age 25. |
| Colorectal | 45 | 40 or 10 yrs before FDR’s diagnosis if FDR had CRC before 60. Age 20–25 for Lynch syndrome. Age 10–12 for FAP. |
| Prostate | 50 (ACS) | Age 45: Black men; first-degree relative with prostate cancer before 65. Age 40: multiple first-degree relatives with early prostate cancer. |
| Pancreatic | No average-risk screening | Age 40–50 for BRCA2, PALB2, ATM carriers; Lynch syndrome; Peutz-Jeghers — NCCN/CAPS protocol. |
Frequently Asked Questions
What cancer screening do I need at age 40?
At 40, most average-risk adults should: (1) begin mammography — USPSTF 2024 updated the start age to 40, recommending biennial mammography covered without cost-sharing under the ACA; ACS recommends annual from 45 but allows starting at 40–44; (2) ensure cervical screening is current if applicable; (3) prepare for CRC screening starting at 45. For men at 40: no new average-risk cancer screening typically starts at 40 unless you have multiple first-degree relatives with early prostate cancer (ACS recommends PSA discussion at 40 for this very high-risk group). If you have a first-degree relative who had CRC before age 50, begin colonoscopy now.
At what age do cancer screenings start for average-risk adults?
The first routine cancer screening is cervical cancer screening — starting at age 21 for women (Pap smear every 3 years; HPV test preferred from 25). Breast cancer mammography now starts at 40 (USPSTF 2024). Colorectal cancer screening starts at 45. Lung cancer LDCT starts at 50 for qualifying smokers. Prostate cancer PSA discussions start at 50 (ACS) or 55 (USPSTF) for average-risk men. Men without smoking history and at average risk have no new cancer screening until the prostate discussion in the 50s.
Is there cancer screening for people in their 20s?
For women: yes — cervical cancer Pap smear starting at age 21 (HPV testing from 25). For men: no routine cancer screening is recommended by USPSTF for average-risk men in their 20s. However, testicular cancer is the most common solid tumor in men aged 20–34 — while routine screening is not recommended, young men should know the signs (painless testicular lump or swelling) and seek prompt evaluation. High-risk individuals in their 20s — BRCA carriers, Lynch syndrome — are already in intensive surveillance programs.
What changes about cancer screening after age 65?
Several important changes: (1) Cervical screening typically stops at 65 with adequate prior history. (2) PSA screening is recommended against by USPSTF at 70+. (3) Breast cancer mammography becomes individualized at 75+, with no clear USPSTF recommendation above that age. (4) CRC screening continues through 75 (Grade A) but becomes individualized for 76–85. (5) Lung LDCT continues through 80 then stops. (6) Medicare Part B covers many screenings free at 65 — mammography, colonoscopy, FIT, Pap smear, PSA, and LDCT for qualifying smokers.
Do I need cancer screening if I feel healthy and have no family history?
Yes. Most cancers caught by screening are found in people who feel completely well — that is the point of screening. Cancer does not reliably produce symptoms in early stages, when treatment is most effective. Feeling healthy does not protect you from cancer; neither does a negative family history, since most cancers (approximately 80–85%) are not primarily hereditary. Follow the age-appropriate screening schedule regardless of how you feel or whether anyone in your family has had cancer.
What screening should I discuss with my doctor if I’m a smoker?
If you are age 50–80, have 20+ pack-years of smoking history, and currently smoke or quit within the past 15 years: discuss annual LDCT lung cancer screening — USPSTF Grade B, covered by most insurance without cost-sharing. Also ensure you’re current on all age-appropriate screenings, since smoking elevates risk for multiple cancer types. Smoking cessation, if you still smoke, remains the most impactful single action available — LDCT is a complement to quitting, not a substitute.
How do I know if I’m at high risk and need earlier screening?
Risk factors that typically trigger earlier or more intensive screening include: a first-degree relative with cancer at a young age; a known hereditary gene variant (BRCA1/2, Lynch syndrome genes, APC, PALB2); personal history of a precancerous condition (Barrett’s esophagus, adenomatous polyps, atypical nevi); prior chest radiation before age 30; being Black (elevated risk for breast, prostate, and CRC); and significant smoking history for lung cancer. If any of these apply, ask your doctor specifically: “Do I need to start screening earlier or more frequently?” and request a formal risk assessment.
- US Preventive Services Task Force (USPSTF) — Breast (2024), Cervical (2018), CRC (2021), Lung (2021), Prostate (2018) recommendations.
- American Cancer Society — Breast (2015), Cervical (2020), CRC (2018), Lung (2023), Prostate (2023) guidelines.
- NCCN — Genetic/Familial High-Risk Assessment, Breast Cancer Screening, Version 1.2024.
- Siegel RL et al. (2020). Colorectal cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70(3), 145–164.
- Centers for Medicare & Medicaid Services (CMS) — Medicare preventive services coverage.